Clinical Oncology
Current issue
Most read in this issue
- Pregnancy-associated EGFR-mutant lung adenocarcinoma in a TB-endemic region – diagnostic bias and therapeutic barriers
- Graft versus host disease as a marker for assessing quality of life in patients after allogeneic hematopoietic cell transplantation – results of a retrospective study
- FLAURA2 – a step forward in first-line treatment of advanced EGFR-mutated non-small cell lung cancer
- With the exception of perinephritic fluid collection, all symptoms of TEMPI syndrome resolved following treatment for Waldenström macroglobulinemia
Journal archive
2026
2025
2024
2023
2022
2021
2020
Issue 6
Issue Supplementum 3
Issue Supplementum - 2
Issue Suppl 1
Issue 4
Issue 5
Issue 3
Issue 2
Issue 1
2019
Issue 6
Issue Supplementum 3
Issue 5
Issue 4
Issue Supplementum2
Issue 3
Issue 2
Issue Supplementum1
Issue 1
2018
2017
Issue 6
Issue Supplementum3
Issue Online only
Issue 5
Issue 4
Issue Supplementum2
Issue 3
Issue Supplementum1
Issue 2
Issue 1
2016
Issue 6
Issue 5
Issue Supplementum 4
Issue Supplementum 3
Issue 4
Issue 3
Issue 2
Issue 1
Issue Supplementum 1
- Hodnocení klinického stadia a léčebné odpovědi u maligních lymfomů – doporučení Kooperativní lymfomové skupiny na základě revidovaných kritérií z roku 2014 (Luganská klasifikace)
- SBORNÍK ABSTRAKT XL. brněnské onkologické dny a XXX. konference pro nelékařské zdravotnické pracovníky 27.–29. 4. 2016, Brno
2015
Issue 6
Issue Supplementum 4
Issue Supplementum 3
Issue 5
Issue 4
Issue Supplementum 2
Issue 3
Issue Supplementum 1
Issue 2
Issue 1
2014
2013
2012
2011
2010
2009
About the journal
- Incidence of Thromboembolic Disease During Military Operations – Results of a 10-Year Review
- Current Recommendations by the ELN Expert Panel on AML Diagnosis Management
- Kadcyla in a New Indication – Adjuvant Therapy for Early HER2+ Breast Cancer
- Evaluation of the m7-FLIPI score in patients with follicular lymphoma revealed a promising predictive biomarker for determining suitable chemotherapy
- Polatuzumab Vedotin in Combination Treatment of Patients with R/R DLBCL